"At ProCure Proton Therapy Center located in Somerset, NJ, we provide cancer patients with exceptional and personalized care with the most advanced proton therapy technology available. A highly advanced form of radiation treatment, proton therapy destroys cancer cells with the utmost precision while sparing surrounding healthy tissue. Welcome Wednesdays: We cordially invite community members who are seeking more information about proton therapy treatment to join us at the Center for an informal education session hosted by one of our physicians. Upcoming sessions: June 10th and July (TBD) from 12:30 pm - 1:30 pm. Our graduation takes place beforehand at 12:00pm, and all are invited. RSVP required for this session - call 877-267-7891."

During the past decade, ProCure Proton Therapy Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProCure Proton Therapy Center" #1 sponsor was "NRG Oncology" with 2 trials, followed by "Abramson Cancer Center at Penn Medicine" with 1 trials sponsored, "Proton Collaborative Group" with 1 trials sponsored, "Radiation Therapy Oncology Group" with 1 trials sponsored and "University of Florida" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProCure Proton Therapy Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "ProCure Proton Therapy Center" are "Adult Giant Cell Glioblastoma" (1 trials), "Adult Glioblastoma" (1 trials), "Adult Gliosarcoma" (1 trials), "Breast Cancer" (1 trials) and "Grade II Meningioma" (1 trials). Many other conditions were trialed in "ProCure Proton Therapy Center" in a lesser frequency.

Most popular intervention types in "ProCure Proton Therapy Center" are "Radiation" (6 trials), "Other" (3 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "3-dimensional conformal radiation therapy" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Clinical Observation" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "ProCure Proton Therapy Center" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ProCure Proton Therapy Center". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ProCure Proton Therapy Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ProCure Proton Therapy Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".